Cliff Asness’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.69M Buy
+1,214,267
New +$2.35M ﹤0.01% 2768
2025
Q4
– Sell
-10,793
Closed -$19.8K – 3567
2025
Q3
$19.8K Sell
10,793
-34,790
-76% -$30.1K ﹤0.01% 3449
2025
Q2
$18.9K Sell
45,583
-73,467
-62% -$37.1K ﹤0.01% 3286
2025
Q1
$74.2K Buy
119,050
+77,065
+184% +$92.5K ﹤0.01% 3056
2024
Q4
$70.1K Buy
41,985
+13,479
+47% +$20.7K ﹤0.01% 2793
2024
Q3
$51.9K Buy
28,506
+10,427
+58% +$38.8K ﹤0.01% 2703
2024
Q2
$109K Buy
18,079
+6,080
+51% +$74.8K ﹤0.01% 2487
2024
Q1
$134K Buy
+11,999
New +$169K ﹤0.01% 2309

Other funds holding ALXO

Cliff Asness's ALXO Position: Q3 2026 in Review

Cliff Asness opened a new position in ALX Oncology (ALXO) in Q3 2026: 1,214,267 shares worth $1.69M. The stake represents ﹤0.01% of the portfolio and ranks #2768 among its holdings. This is a return to the name: Cliff Asness previously reported a position in ALXO as recently as Q3 2025.

Cliff Asness first reported a position in ALXO in Q1 2024 and has held it in 8 quarters since. 112 funds tracked by Wall St. Rank hold ALXO as of Q3 2026.

  • Cliff Asness held 1,214,267 shares of ALX Oncology worth $1.69M as of Q3 2026.
  • ALX Oncology was a new Cliff Asness position in Q3 2026.
  • ALX Oncology made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #2768 holding.
  • Cliff Asness first reported a position in ALX Oncology in Q1 2024 and has held it in 8 quarters since.
  • 112 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2026.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.